查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390431

2023-2028 年按手術、產品、最終用戶和地區分類的神經修復和再生市場報告

Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球神經修復與再生市場規模達77億美元。展望未來， IMARC Group預計到2028年市場規模將達到148億美元，2022-2028年複合年成長率（CAGR）為11.51%。

神經修復和再生（NRaR）是指用於治療神經損傷的神經組織工程過程。它促進新神經元、神經膠質細胞、髓鞘、軸突和突觸的再生。它還有助於在神經損傷後恢復神經的正常功能，神經損傷通常是由壓力、鈍性創傷、神經拉伸或切割引起的。 NRaR 涉及生物材料和各種神經刺激和神經調節設備的使用。生物材料包括神經導管、神經保護器、神經包裹物和神經連接器。它們用於直接神經病變、神經移植、幹細胞治療以及經皮、經顱磁、脊髓、深部腦、骶神經和迷走神經刺激。

神經修復與再生市場趨勢：

阿茲海默症、帕金森氏症、肌萎縮側索硬化症、多發性硬化症和多重系統退化症症等慢性神經系統疾病的盛行率不斷增加，是推動市場成長的關鍵因素之一。此外，老年人口的增加（更容易患此類疾病）以及神經損傷病例的不斷增加都推動了市場的成長。全球各地的醫院、門診手術中心 (ASC) 和其他醫療機構正在提供新穎的 NRaR 解決方案，以及時診斷和治療神經系統疾病。此外，幹細胞治療的各種技術進步和創新神經調節裝置的開發也起到了其他生長誘導因素的作用。內源性幹細胞廣泛應用於神經發生、神經修復和外源性神經幹細胞移植，以有效修復和取代中樞神經系統受損組織。其他因素，包括大眾醫療保健支出的增加，以及醫療基礎設施的顯著改善，特別是在發展中經濟體，預計將推動市場成長。

本報告回答的關鍵問題

  • 2022年全球神經修復再生市場規模有多大？
  • 2023-2028年全球神經修復和再生市場的預期成長率是多少？
  • 推動全球神經修復和再生市場的關鍵因素是什麼？
  • COVID-19 對全球神經修復和再生市場有何影響？
  • 基於手術的全球神經修復和再生市場的分化是什麼？
  • 基於該產品的全球神經修復和再生市場的詳細情形如何？
  • 基於最終用戶的全球神經修復和再生市場的細分是什麼？
  • 全球神經修復與再生市場的關鍵區域有哪些？
  • 全球神經修復和再生市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球神經修復與再生市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：透過手術進行市場細分

  • 直接神經修復/神經縫合術
    • 市場走向
    • 市場預測
  • 神經移植
    • 市場走向
    • 市場預測
  • 幹細胞治療
    • 市場走向
    • 市場預測
  • 神經刺激與神經調節手術
    • 市場走向
    • 市場預測

第 7 章：按產品分類的市場區隔

  • 生物材料
    • 市場走向
    • 市場預測
  • 神經刺激和神經調節設備
    • 市場走向
    • 關鍵環節
      • 脊髓刺激裝置
      • 深部腦部刺激裝置
      • 薦神經刺激裝置
      • 迷走神經刺激裝置
      • 胃電刺激裝置
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Alafair Biosciences Inc.
    • AxoGen Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Collagen Matrix Inc.
    • Integra Lifesciences Corporation
    • Medtronic plc
    • Polyganics BV
    • Soterix Medical Inc.
    • Stryker Corporation
    • Synapse Biomedical Inc.
Product Code: SR112023A4159

Abstract

The global nerve repair and regeneration market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.51% during 2022-2028.

Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.

Nerve Repair and Regeneration Market Trends:

The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nerve repair and regeneration market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on surgery, product and end user.

Breakup by Surgery:

Direct Nerve Repair/Neurorrhaphy

Nerve Grafting

Stem Cell Therapy

Neurostimulation and Neuromodulation Surgeries

Breakup by Product:

Biomaterial

Neurostimulation and Neuromodulation Devices

Spinal Cord Stimulation Devices

Deep Brain Stimulation Devices

Sacral Nerve Stimulation Devices

Vagus Nerve Stimulation Devices

Gastric Electric Stimulation Devices

Breakup by End User:

Hospitals and Clinics

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alafair Biosciences Inc., AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Collagen Matrix Inc., Integra Lifesciences Corporation, Medtronic plc, Polyganics BV, Soterix Medical Inc., Stryker Corporation and Synapse Biomedical Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global nerve repair and regeneration market in 2022?
  • 2. What is the expected growth rate of the global nerve repair and regeneration market during 2023-2028?
  • 3. What are the key factors driving the global nerve repair and regeneration market?
  • 4. What has been the impact of COVID-19 on the global nerve repair and regeneration market?
  • 5. What is the breakup of the global nerve repair and regeneration market based on the surgery?
  • 6. What is the breakup of the global nerve repair and regeneration market based on the product?
  • 7. What is the breakup of the global nerve repair and regeneration market based on the end user?
  • 8. What are the key regions in the global nerve repair and regeneration market?
  • 9. Who are the key players/companies in the global nerve repair and regeneration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nerve Repair and Regeneration Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Surgery

  • 6.1 Direct Nerve Repair/Neurorrhaphy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Nerve Grafting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Stem Cell Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Neurostimulation and Neuromodulation Surgeries
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurostimulation and Neuromodulation Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Spinal Cord Stimulation Devices
      • 7.2.2.2 Deep Brain Stimulation Devices
      • 7.2.2.3 Sacral Nerve Stimulation Devices
      • 7.2.2.4 Vagus Nerve Stimulation Devices
      • 7.2.2.5 Gastric Electric Stimulation Devices
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alafair Biosciences Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AxoGen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Collagen Matrix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Integra Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Polyganics BV
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Soterix Medical Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Synapse Biomedical Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nerve Repair and Regeneration Market: Major Drivers and Challenges
  • Figure 2: Global: Nerve Repair and Regeneration Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Nerve Repair and Regeneration Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Nerve Repair and Regeneration Market: Breakup by Surgery (in %), 2022
  • Figure 5: Global: Nerve Repair and Regeneration Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Nerve Repair and Regeneration Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Nerve Repair and Regeneration Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Nerve Repair and Regeneration (Nerve Grafting) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Nerve Repair and Regeneration (Nerve Grafting) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Nerve Repair and Regeneration (Biomaterial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Nerve Repair and Regeneration (Biomaterial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Nerve Repair and Regeneration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Nerve Repair and Regeneration Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Nerve Repair and Regeneration Industry: SWOT Analysis
  • Figure 74: Global: Nerve Repair and Regeneration Industry: Value Chain Analysis
  • Figure 75: Global: Nerve Repair and Regeneration Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nerve Repair and Regeneration Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Surgery (in Million US$), 2023-2028
  • Table 3: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Nerve Repair and Regeneration Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Nerve Repair and Regeneration Market: Competitive Structure
  • Table 7: Global: Nerve Repair and Regeneration Market: Key Players